Known Medicine

Known Medicine is an early-stage, private biotech company founded in 2020, headquartered in San Francisco with significant R&D operations in Salt Lake City. The company is developing a functional precision oncology platform that combines high-throughput 3D cell culture of patient tumors, automated imaging, and machine learning to predict individual patient responses to hundreds of drugs and combinations. By creating a massive, purpose-built dataset of tumor-drug interactions, Known Medicine seeks to improve clinical trial success rates and enable more effective, personalized cancer therapy. The company is currently pre-revenue and in a platform validation and development stage.

A machine learning-based functional precision oncology platform that uses high-throughput 3D cell culture of patient tumors, automated imaging, and multi-omics integration to observe and predict tumor response to hundreds of drugs and combinations.

Known Medicine competes with other functional precision oncology companies like Exscientia (AI-driven), Recursion (high-content phenomics), and numerous academic spin-offs. It also faces indirect competition from dominant NGS-based genomic profiling firms (e.g., Foundation Medicine, Guardant Health). Its differentiation lies in its integrated, high-throughput 3D culture and imaging approach focused purely on observable phenotypic response.